← FDA DRUG APPROVALS

FDA ANDA · ANDA086821

HYDROXYZINE HYDROCHLORIDE

Sponsor: HOSPIRA

APPLICATION
ANDA086821
TYPE
ANDA
ORIGINAL APPROVAL
1979-09-05
LATEST ACTION
1998-05-05
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

HYDROXYZINE HYDROCHLORIDEDiscontinued
HYDROXYZINE HYDROCHLORIDE 50MG/ML · INJECTABLE · INJECTION

Approval history

1998-05-05Manufacturing (CMC) · Supplement 13AP
1997-01-16Manufacturing (CMC) · Supplement 11AP
1996-10-03Manufacturing (CMC) · Supplement 12AP
1982-05-24Manufacturing (CMC) · Supplement 7AP
1982-05-24Manufacturing (CMC) · Supplement 8AP
1979-09-05OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →